Excellent Options Movers

Exciting Options Activity

We’ve been having an excellent week for options, and saw some new highs in the PTON Calls we submitted in Tuesday morning’s report, as well as some nice activity out of the starting gate for a couple of our fresh options ideas. We went to the short side on EA and long on CLVS, and in both cases we were able to reap instant rewards.

PTON Weekly $34-35 Calls
2.96-6.10 (+106%)
$35: 2.41-5.40 (+124%)

Just as we mentioned yesterday, we expect to see these PTON gains increased today, based on premarket activity in the stock. We’re also going to include the PTON 05/15 $42-44 Calls in our watchlist. 

EA Weekly $120-115 Puts
4.03-7.73 (+92%)
$119: 3.00-7.00 (+133%)
$118: 2.40-5.07 (+111%)
$117: 1.88-5.00 (+166%)
$116: .95-4.00 (+321%)
$115: 1.34-3.50 (+161%)

CLVS Weekly $8-8.50 Calls 
$8: .55-1.35 (+145%)
$8.50: .25-.90 (+260%)

Fresh Ideas:
VIAC Weekly $16-18 Calls
FVRR 05/15 $45-55 Calls
MRNA Weekly $53.50-55 Calls
PYPL Weekly $135-145 Calls

Extended Watchlist:

Blue Horseshoe Stocks: Commenting on PBR & More

Petroleo Brasiliero S.A. (Petrobras) PBR

Amid allegations of money-laundering and bribery which extend high up into the Brazilian government (including former PBR board member and President Dilma Rousseff) the sixth-largest energy company in the world, and a point of focus for us all year, could be forced to write down billions in assets and reduce dividends. The company’s Q3 financials are being delayed indefinitely as a result.

The long-term implications of such a scandal are too vast and varied for us to make even a brief assessment accurately. What we can do is stay extra tuned to the PBR newsfeed to stay as up-to-date as possible on current events and adhere to our technicals, because we can still see potential on the chart.

On Tuesday, PBR hit its all-time low of 8.80. but has since made higher lows and higher highs over the proceeding sessions. After we tagged it on Friday morning, there was a 9% intraday move from 10.08 to $11, and this morning the premarket high is 11.51, which will act as immediate resistance as the session kicks off. We’ll want to see support hold at roughly 10.85, but if PBR can break past this morning’s high to confirm its continued uptrend, the next thing we’d be looking for is the filling of a gap on the chart from approximately $12-12.50.

As far as options go, we’re presently looking at the Jan 17th $10 and $11 Calls, provided the current trend continues.

Prosensa Holdings (N.V.) RNA

RNA is a stock that we tracking periodically this spring and summer, and we just wanted to comment quickly on the buyout offer the company announced this morning. In a $680M deal, Prosensa will receive around $17.75/share from buyer BioMarin Pharmaceutical.

Following an alert we put out on RNA back in May, the stock was trading at a low of 7.96; this morning’s premarket high of $19 means we’ve seen more than a 130% move in this play over a span of about 5 months.

Extended Watchlist:

Blue Horseshoe Stocks: ACGX Update

Alliance Creative Group, Inc. ACGX

We thought today would be a good time to revisit ACGX given the current positioning of the chart. For some of our newer readers; this was a play that has afforded us the chance at some stellar gains over the past couple of months.

Following a huge run to more than a penny back in April, we monitored ACGX for a bottom, which it found at .0035 (May 9th). Since that time, it has made a couple of significant swings, where it has run into some resistance at the .006-.0064 area. We are currently observing another strong move off of its most recent swing-low, with the stock having made higher lows for the past five consecutive sessions.

As you can see on the included chart, ACGX is on the fringe of cracking through its 50DMA, the RSI is about to flip up to the strong side, and the MACD appears to be setting up for a bullish cross. With these factors in alignment, we’re going to want to pay closer attention to ACGX over the course of the week.

Remember, per a recent PR, at the end of the month Alliance will be attending the 1st Annual Weedstock Conference in Denver (June 29-July 1), so we’ll be interested to receive an update on that come July.

More Info:

Provectus Biopharmaceuticals, Inc. PVCT

We spotted PVCT on a routine scan this morning, and wanted to include it given the current situation. The stock recently became the target of an upcoming class action lawsuit, and was actually halted on May 23rd. this led to a major selloff when trading resumed, triggering a gap-down.

It appears as if the firm handling suit has another couple of months to pull together plaintiffs for the case, so we’ll be long gone by the time that comes around. We are interested in PVCT purely for the potential for quick-strike opportunities as it corrects itself off of its recent lows in the .30-.70 range.

The re-filling of even a fraction of the gap on the chart could mean rapid profits for us, so we’ll be keeping an eye on this stock over the next few sessions.

Extended Watchlist: